Nephrotic syndrome risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Multiple risk factors may be involved in the nephrotic syndrome, such as family history, gender, and obesity. Also, diseases such as Hodgkin lymphoma, leukemia, viral diseases, and medications such as lithium, D-penicillamine can be risk factors for developing different types of nephrotic syndromes.
Risk factors
Risk factors of nephrotic syndrome depend on the type of syndromes, as below:
Common risk factors
Risk factors of development of minimal change disease include:[1]
- Children within the Age >1 year but <8 years
- Hodgkin lymphoma
- Leukemia
- Recent viral illness
- Toxins such as mercury, gold, bee stings, fire coral exposure.
- Medication such as[2]
- Salazopyrin
- Tiopronin
- Lithium
- D-penicillamine
- Tyrosine-kinase inhibitor
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):[3]
- Male gender
- Black race
- Family history
- Heroin abuse
- Drugs known to be associated with FSGS
- Chronic viral infection
- Single kidney status
- Obesity
Less common risk factors
Below conditions and toxins can be a risk factor for nephrotic syndrome[4]
- Adaptation to nephron reduction
- Amyloidosis
- Bee sting
- Castleman’s disease
- Chronic interstitial nephritis
- Dermatomyositis
- Diabetes mellitus
- Endocarditis
- Fabry’s disease
- Food allergens
- Gold
- Goodpasture’s syndrome
- Graft vs. host disease
- Henoch-Schonlein purpura
- Heroin
- HIV
- Infectious mononucleosis
- Interferon
- Kimura’s disease
- Leukemia
- Lipoatrophy
- Lithium
- Lymphomas
- Malaria
- Mercury
- Mixed connective tissue disease
- Multiple myeloma
- NSAID
- Obesity
- Oligomeganephronia
- Orthostatic proteinuria
- Penicillamine
- Polyarteritis nodosa
- Pre-eclampsia
- Probenecid
- Renal vein thrombosis
- Rheumatoid arthritis
- Sarcoidosis
- Sickle cell anemia
- Sjogren’s syndrome
- Sorafenib
- Streptococcal Infection
- Syphillis
- Systemic lupus erythematosus
- Thyroid disease
- Toxoplasmosis
- Vasculitis
- Viral hepatitis
Drug Induced
References
- ↑ Iijima, Kazumoto; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kobayashi, Akiko; Nozu, Kandai; Nakamura, Hajime; Yoshikawa, Norishige (2002). “Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome”. Kidney International. 61 (5): 1801–1805. doi:10.1046/j.1523-1755.2002.00303.x. ISSN 0085-2538.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). “Minimal Change Disease”. Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Sohal, DS; Prabhakar, SS (November 02, 2011). “Focal segmental glomerulosclerosis” (PDF). Interchopen. InTech. Retrieved 3 December 2013. Check date values in:
|date=(help) - ↑ Eddy AA, Symons JM (2003). “Nephrotic syndrome in childhood”. Lancet. 362 (9384): 629–39. doi:10.1016/S0140-6736(03)14184-0. PMID 12944064.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH